metricas
covid
Buscar en
Neurología (English Edition)
Toda la web
Inicio Neurología (English Edition) Spinal dural arteriovenous fistulas: early endovascular treatment or surgery?
Información de la revista
Vol. 34. Núm. 8.
Páginas 557-560 (octubre 2019)
Vol. 34. Núm. 8.
Páginas 557-560 (octubre 2019)
Letter to the Editor
Open Access
Spinal dural arteriovenous fistulas: early endovascular treatment or surgery?
Fístulas arteriovenosas espinales durales: ¿tratamiento precoz endovascular o quirúrgico?
Visitas
3664
R. Prietoa,
Autor para correspondencia
rprieto29@hotmail.com

Corresponding author.
, J.M. Pascualb, L. Barriosc
a Servicio de Neurocirugía, Hospital Puerta de Hierro, Majadahonda, Madrid, Spain
b Servicio de Neurocirugía, Hospital La Princesa, Madrid, Spain
c Departamento de Estadística, Investigación Operativa y Estadística Aplicada, Consejo Superior de Investigaciones Científicas, Madrid, Spain
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Tablas (1)
Table 1. Series of patients with spinal dural arteriovenous fistulas published in the past 20 years.a
Texto completo
Dear Editor:

It was with great interest that we read the article “Spinal arteriovenous fistulas in adults: management of a series of patients treated at a neurology department” by Ortega-Suero et al.1 In this study, the authors retrospectively analyse the outcomes in a series of 10 patients with spinal arteriovenous fistulas (AVF) treated at their hospital over a 3-year period. Firstly, we wish to congratulate the authors on their series, the second modern series of patients with spinal AVFs to be published in Spain.1,2 Ortega-Suero et al.1 include 6 cases of spinal dural AVFs; we will focus on this type of AVF since they represent 75% of all spinal vascular malformations. We agree that spinal dural AVFs are difficult to diagnose despite considerable advances in neuroimaging techniques. Though rare, this type of AVF should be included in the differential diagnosis of patients with symptoms of progressive myelopathy and/or radiculopathy, given the poor neurological outcomes associated with late diagnosis and treatment. Up to 25%-30% of patients present paraplegia by the time spinal dural AVF is diagnosed.3 Furthermore, a considerable percentage of patients will already have undergone unnecessary spine surgery following incorrect aetiological diagnosis of their neurological symptoms, which are often attributed to spinal canal stenosis, spondylolisthesis, or disc herniation.4,5 The optimal treatment for spinal dural AVFs is also controversial, with either endovascular therapy or surgery constituting the treatment of choice. The purpose of this letter is to comment on 2 fundamental aspects of treatment for spinal dural AVFs: 1) patients may present rapidly progressive neurological deterioration; in these cases, early occlusion of the fistula should be considered even if the patient already presents paraplegia (neurological improvement has been reported in most cases of early treatment); and 2) analysis of recent case series shows that, despite continuous improvements, endovascular treatment continues to be less effective than surgery; the latter achieves higher rates of complete dural AVF occlusion and is associated with a low morbidity rate.

Patients with spinal dural AVFs may display severe, rapidly progressive neurological deterioration characterised by lower limb paralysis and sphincter dysfunction, known as Foix-Alajouanine syndrome; the pathophysiology is yet to be fully understood.3 The syndrome has traditionally been thought to be caused by irreversible necrotising myelopathy secondary to venous thrombosis. The high rates of improvement following treatment for spinal dural AVFs, even in patients with complete paraplegia, demonstrate that functional spinal cord alterations underlying severe neurological impairment may be due to decreased nervous tissue perfusion secondary to venous hypertension.3,5,6 Severe, prolonged reduction of spinal cord perfusion pressure may lead to spinal cord infarction, which may explain why symptom duration, rather than the degree of neurological impairment at diagnosis, is the main prognostic factor in spinal dural AVFs.3,4,7 Eight years ago, our research group published a study of the prognosis of 107 patients with spinal dural AVFs and paraplegia at the time of treatment. Symptoms improved after treatment in approximately 75% of patients. However, improvements were limited in most cases, with fewer than 6% of patients being able to walk without assistance.3 Lack of complete recovery in most of these patients was most likely due to diagnostic delays: mean time from symptom onset to definitive diagnosis was 20 months.3 In our study, paraplegia duration was less than 24hours in approximately two-thirds of patients with paraplegia secondary to a spinal dural AVF and showing neurological improvement (from an Aminoff-Logue scale score for gait disturbance of 5 [wheelchair-bound] to 1 [leg weakness but no restriction of activity]) after treatment. In the remaining patients displaying such a marked clinical improvement, the mean time of progression of neurological deficits was shorter than 2 months.3 According to other series, patients with longer symptom progression times are less likely to display significant improvements after surgery.4,7 Spinal dural AVFs should therefore be considered in the differential diagnosis of patients with rapidly progressive lower limb weakness, paraesthesia, and/or sphincter dysfunction of undetermined origin, particularly in elderly patients displaying unusually fast symptom progression.

Regarding the optimal treatment for spinal dural AVFs, advances in embolisation techniques, with the use of liquid agents that can be introduced into the draining vein, enable treatment of the fistula during diagnostic arteriography, and have led to increases in the rate of endovascular treatment in many centres. Training for young neurosurgeons in cerebrovascular disease and spinal vascular malformations is currently lacking; in Spain, this has led to a predominance of endovascular treatment over surgery, as demonstrated by the series of patients treated between 2012 and 2015 published by Ortega-Suero et al.1 However, recent case series of spinal dural AVFs published by the most relevant international research groups show that surgery was the initial treatment for occlusion of the fistula in nearly 60% of patients (Table 1).2,3,5,7–24 Despite the heterogeneity of these series, all show better angiographic and clinical outcomes in patients undergoing surgery than in those undergoing endovascular treatment. The percentage of complete, permanent obliteration of the spinal dural AVF in a single procedure was nearly 100% among patients undergoing surgery, compared to 61% in patients receiving endovascular treatment. Differences in clinical outcomes were more marked: nearly 80% of surgery patients presented clinical improvements, compared to only 63% of those undergoing endovascular treatment. Furthermore, some series report poorer clinical prognosis in patients undergoing surgery following failure of endovascular treatment, whether due to incomplete occlusion of the fistula or to recanalisation.14,18

Table 1.

Series of patients with spinal dural arteriovenous fistulas published in the past 20 years.a

Author, year  No. patients  No. patients with paraplegia  Mean time to diagnosis (months)  No. acute cases  Initial treatmentComplete obliteration with initial treatment (%)Overall clinical improvement (%)Morbidity (%)
          Embolisation  Surgery  Embolisation  Surgery  Embolisation  Surgery  Embolisation  Surgery 
Atkinson et al.8 2001  94  30  23  94  NA  99  NA  98  NA 
Song et al.9 2001  30  29  NA  23  78  100  57NA  NA 
Van Dijk et al.10 2002  49  NA  27.6  44  25  97.2  924.5  2.7 
Cenzato et al.11 2004  37  22  NA  13  24  77  100  78
Jellema et al.12 2004  44  13  13.8  NA  34  10  54  100  7010 
Steinmetz et al.13 2004  19  19.2  19  NA  100  NA  44  NA  5.2 
Andres et al.14 2008  21  NA  NA  17  58  100  65  100 
Cecchi et al.15 2008  25  18  21  100  40
Narvid et al.16 2008  69  46  19  NA  39  24  69  80  65  50 
Park et al.17 2008  18  14.4  17  76.5  100  82.3  100 
Prieto et al.3 2009  107  107  20.4  25  82  58  97  73NA  NA 
Saladino et al.5 2010  154  24.7  20  154  NA  95  NA  82  NA 
Ruiz-Juretschke et al.2 2011  19  12  10  55.6  100  44  70  16
Clark et al.18 2013  23  12  15  46  90  18  70  NA  NA 
Cho et al.19 2013  32  21  27  85  100  5018  20 
Gemmete et al.20 2013  33  NA  24.6  NA  29  82  100  453.4 
Kirsch et al.21 2013  78  NA  13.9  NA  61  17  72  100  73.61.6 
Gokhale et al.7 2014  27  11  NA  10  17  70  100  8110  11.7 
Schuss et al.22 2015  29  NA  21  29  NA  100  NA  76  NA 
Gross et al.23 2017  71  NA  NA  28  42  50  100  80  80  11  11 
Koch et al.24 2017  34  NA  16  20  14  65  100  85  93  15  14 
Total  1013  269  19  64  406  581  61  98  63  78 

NA: not available.

a

We only included series with more than 15 patients.

Microsurgical occlusion of spinal dural AVFs is associated with a morbidity rate of approximately 5%, similarly to that observed for endovascular treatment. However, embolisation is associated with more severe complications, which often irreversibly affect neurological function. Introducing embolic material through a catheter should not be considered non-invasive, since it is associated with a considerable risk of migration of embolic material into the venous system and/or radicular artery rupture, potentially leading to such severe outcomes as spinal cord infarction, causing permanent, irreversible motor function loss in the areas supplied by nerves emerging from below the level of the infarction.7,19,21,23 Furthermore, patients undergoing embolisation are exposed to a radiation dose above 5Gy.24 In contrast, the most frequent complications of surgery include cerebrospinal fluid fistulas and pseudomeningocele, which are never associated with permanent neurological deficits. Surgical treatment of spinal dural AVFs consists of disconnection between the dural artery and the intradural draining vein; this technique is relatively easy to perform when the lesion has been correctly diagnosed and located intraoperatively (Fig. 1). The main technical difficulties for less experienced surgeons are determining the precise location of the lesion during the procedure and confirming complete occlusion of the fistula. Both problems have partially been solved with the introduction of indocyanine green, a fluorescent contrast agent enabling the differentiation of arterial from venous blood flow in spinal dural AVFs. Based on the above, we may conclude that microsurgical occlusion of the fistula continues to be the safest and most effective treatment for spinal dural AVFs, regardless of recent advances in endovascular treatment, and should therefore be considered the first-line treatment for these patients. Embolisation should be considered in patients with severe comorbidities contraindicating surgery.

Figure 1.

Spinal angiography and intraoperative photographs of a spinal dural arteriovenous fistula affecting the right radicular artery at the level of T11. (A) Selective angiography showing a fistula below the right pedicle of T11 (asterisk), connecting the radiculomeningeal artery and a varicose perimedullary vein (white arrow). (B) Intraoperative photograph following T11 laminectomy and durotomy, showing arterialisation of tortuous perimedullary veins (black arrow), in close contact with the nerve root (black arrowhead). (C) Clipping (white arrows), coagulation, and excision of the draining vein at the level of the nerve root results in immediate collapse and darkening of perimedullary veins (black arrow). (D) Postoperative spinal angiography showing complete occlusion of the fistula; the arrows indicate the vascular clips.

(0.42MB).
References
[1]
G. Ortega-Suero, J. Porta Etessam, M. Moreu Gamazo, G. Rodríguez-Boto.
Fístulas arteriovenosas espinales del adulto. Manejo de una serie de casos desde una planta de Neurología.
[2]
F. Ruiz-Juretschke, J.M. Perez-Calvo, E. Castro, R. García-Leal, O. Mateo-Sierra, F. Fortea, et al.
A single center, long-term study of spinal dural arteriovenous fistulas with multidisciplinary treatment.
J Clin Neurosci, 18 (2011), pp. 1662-1666
[3]
R. Prieto, J.M. Pascual, R. Gutiérrez, E. Santos.
Recovery from paraplegia after the treatment of spinal arteriovenous fistula: case report and review of the literature.
Acta Neurochir. (Wien), 151 (2009), pp. 1385-1397
[4]
I. Iovtchev, N. Hiller, Y. Ofran, I. Schwartz, J. Cohen, S.A. Rubin, et al.
Late diagnosis of spinal dural arteriovenous fistulas resulting in severe lower-extremity weakness: a case series.
[5]
A. Saladino, J.L. Atkinson, A.A. Rabinstein, D.G. Piepgras, W.R. Marsh, W.E. Krauss, et al.
Surgical treatment of spinal dural arteriovenous fistulae: a consecutive series of 154 patients.
Neurosurgery, 67 (2010), pp. 1350-1358
[6]
H. Joswig, F.A. Haji, R. Martinez-Perez, D.A. Steven, M.R. Boulton.
Rapid recovery from parapegia in a patient with Foix-Alajouanine syndrome.
World Neurosurg, 97 (2017), pp. 750.e1-750.e3
[7]
S. Gokhale, S.A. Khan, D.L. McDonagh, G. Britz.
Comparison of surgical and endovascular approach in management of spinal dural arteriovenous fistulas: a single center experience of 27 patients.
Surg Neurol Int, 5 (2014), pp. 7
[8]
J.L. Atkinson, G.M. Miller, M.E. Krauss, W.R. Marsch, D.G. Piepgras, P.P. Atkinson, et al.
Clinical and radiographic features of dural arteriovenous fistula, a treatable cause of myelopathy.
Mayo Clin. Proc., 76 (2001), pp. 1120-1130
[9]
J.K. Song, F. Viñuela, Y.P. Gobin, G.R. Duckwiler, Y. Murayama, I. Kureshi, et al.
Surgical and endovascular treatment of spinal dural arteriovenous fistulas: long-term disability assessment and prognostic factors.
J. Neurosurg., 94 (2001), pp. 199-201
[10]
J.M. Van Dijk, K.G. TerBrugge, R.A. Willinsky, R.I. Farb, C. Wallace.
Multidisciplinary management of spinal dural arteriovenous fistulas: clinical presentation and long-term follow-up in 49 patients.
[11]
M. Cenzato, P. Versari, C. Righi, F. Simionato, C. Casali, M. Giovanelli.
Spinal dural arteriovenous fistulae: analysis of outcome in relation to pretreatment indicators.
Neurosurgery, 55 (2004), pp. 815-823
[12]
K. Jellema, C.C. Tijssen, W.J. van Rooij, M. Sluzewski, P.J. Koudstaal, A. Algra, et al.
Spinal dural arteriovenous fistulas: long-term follow-up of 44 treated patients.
[13]
M. Steinmetz, M.M. Chow, A.A. Krishnaney, D. Andrews-Hinders, E.C. Benzel, T.J. Masaryk, et al.
Outcome after the treatment of spinal dural arteriovenous fistulae: a contemporary single-institution series and meta-analysis.
[14]
R.H. Andres, A. Barth, R. Guzman, L. Remonda, M. El-Koussy, R.W. Seiler, et al.
Endovascular and surgical treatment of spinal dural arteriovenous fistulas.
Neuroradiology, 50 (2008), pp. 869-876
[15]
P.C. Cecchi, A. Musumeci, F. Faccioli, A. Bricolo.
Surgical treatment of spinal dural arterio-venous fistulae: long-term results and analysis of prognostic factors.
Acta Neurochir. (Wien), 150 (2008), pp. 563-570
[16]
J. Narvid, S.W. Hetts, D. Larsen, J. Neuhaus, T.P. Singh, H. McSwain, et al.
Spinal dural arteriovenous fistulae: clinical features and long-term results.
Neurosurgery, 62 (2008), pp. 159-167
[17]
S.B. Park, M.H. Han, T.A. Jahng, B.J. Keon, C.K. Chung.
Spinal dural arteriovenous fistulas: clinical experience with endovascular treatment as a primary therapeutic modality.
J Korean Neurosurg Soc, 44 (2008), pp. 364-369
[18]
S. Clark, G. Powell, J. Kandasamy, M. Lee, H. Nahser, T. Pigott.
Spinal dural arteriovenous fistulas – presentation, management and outcome in a single neurosurgical institution.
Br. J. Neurosurg., 27 (2013), pp. 465-470
[19]
W.S. Cho, K.J. Kim, O.K. Kwon, C.H. Kim, J. Kim, M.H. Han, et al.
Clinical features and treatment outcomes of spinal arteriovenous fistulas and malformation: clinical article.
J Neurosurg Spine, 19 (2013), pp. 207-216
[20]
J.J. Gemmete, N. Chaudhary, A.E. Elias, A.K. Toma, A.S. Pandey, R.A. Parker, et al.
Spinal dural arteriovenous fistulas: clinical experience with endovascular treatment as a primary therapy at 2 academic referral centers.
Am. J. Neuroradiol., 34 (2013), pp. 1974-1979
[21]
M. Kirsch, E. Berg-Dammer, C. Musahl, H. Bäzner, D. Kühne, H. Henkes.
Endovascular management of spinal dural arteriovenous fistulas in 78 patients.
Neuroradiology, 55 (2013), pp. 337-343
[22]
P. Schuss, F.H. Daher, S. Greschus, H. Vatter, E. Güresir.
Surgical treatment of spinal dural arteriovenous fistula: management and long-term outcome in a single-center series.
World Neurosurg, 83 (2015), pp. 1002-1005
[23]
B.A. Gross, F.C. Albuquerque, K. Moon, C.G. McDougall.
Validation of an ‘endovascular-first’ approach to spinal dural arteriovenous fistulas: An intention-to-treat analysis.
J Neurointerv Surg, 9 (2017), pp. 102-105
[24]
M.J. Koch, C.J. Stapleton, P.K. Agarwalla, C. Torok, J.H. Shin, J.V. Coumans, et al.
Open and endovascular treatment of spinal dural arteriovenous fistulas: a 10-year experience.
J Neurosurg Spine, 26 (2017), pp. 519-523

Please cite this article as: Prieto R, Pascual JM, Barrios L. Fístulas arteriovenosas espinales durales: ¿tratamiento precoz endovascular o quirúrgico?. Neurología. 2019;34:557–560.

Copyright © 2017. Sociedad Española de Neurología
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos